(3.230.143.213)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 1
First page : ( 135) Last page : ( 141)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00026.X

Development and Evaluation of Robust RP-HPLC Method for Gliclazide Estimation Integrating Box Behnken Design

Dholakia Mansi S.1,*, Rana Hardik B.2, Desai Saloni2, Gohel Mukesh C.2, Patel Kalpana G.2, Thakkar Vaishali T.2, Gandhi Tejal R.2

1Faculty of Pharmacy, Dharamsinh Desai University, Nadiad-387001, Gujarat, India

2Department of Pharmaceutics, Anand Pharmacy College, Anand-388 001, Gujarat, India

*Corresponding Author E-mail: dholakiamansi@gmail.com

Online published on 16 March, 2019.

Abstract

A selective, precise and accurate RP-HPLC method was developed and validated for rapidly determining the quantity of gliclazide in pharmaceutical dosage form. Isocratic elution was employed on a Phenomenex C18 column at a flow rate of 1.2 ml/min. The mobile phase consisted of methanol and 0.02 M potassium dihydrogen orthophosphate (70: 30%v/v). Gliclazide was detected at 210 nm wavelength using UV detector. Linearity was observed in concentration range of 1–100 μg/ml. Retention time of gliclazide retention time was found to be 6.06 min. Validation of developed method was performed as per the ICH guideline. Experimental design approach was used for confirmation of robustness by using Box-Behnken Design with a total 17 runs. The newer method is found to be promising for the estimation of gliclazide in unit or bulk pharmaceutical dosage form.

Top

Keywords

Gliclazide, RP-HPLC, validation, Box-Behnken Design, Robustness.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
739,412,592 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.